NIOSOMES , GENERAL CHARACTERISTICS OF NIOSOME , TYPES OF NIOSOMES , OTHERS TYPES OF NIOSOMES , NIOSOMES VS LIPOSOMES , COMPONENTS OF NIOSOMES , Non-ionic surfactant , Cholesterol , Charge inducing molecule , METHOD OF PREPARATION , preparation of small unilamellar vesicles , Sonication , Micro fluidization , preparation of large unilamellar vesicles , Reverse Phase Evaporation , Ether Injection , preparation of Multilamellar vesicles , Hand shaking method , Trans membrane pH gradient drug uptake process (remote loading) , Miscellaneous method :Multiple membrane extrusion method , The “Bubble” Method , Formation of Niosomes From Proniosomes , SEPARATION OF UNENTRAPPED DRUGS , Gel Filtration , Dialysis , Centrifugation , FACTORS AFFECTING THE PHYSICOCHEMICAL PROPERTIES OF NIOSOMES , Membrane Additives , Temperature of Hydration , PROPERTIES OF DRUGS , AMOUNT AND TYPE OF SURFACTANT
Structure of Surfactants , Resistance to Osmotic Stress , Characterization of niosomes ,Therapeutic applications of Niosomes , For Controlled Release of Drugs , To Improve the Stability and Physical Properties of the Drugs , For Targeting and Retention of Drug in Blood Circulation , Proniosomes , Aspasomes , Vesicles in Water and Oil System (v/w/o) ,Bola - niosomes , Discomes , Deformable niosomes or elastic niosomes , According to the nature of lamellarity ,Small Unilamellar vesicles (SUV) 25 – 500 nm in size.,Large Unilamellar vesicles (LUV) 0.1 – 1μm in size , Multilamellar vesicles (MLV) 1-5 μm in size , According to the size:Small Niosomes (100 nm – 200 nm) , Large Niosomes (800 nm – 900 nm),Big Niosomes (2 μm – 4 μm)
Introduction
Structure
Niosomes Vs. Liposome
Advantages & Disadvantages
Properties of Niosomes
Method of Manufacturing
Evaluation of Niosomes
Applications
Marketed products
Mucoadhesive drug delivery system interact with the mucus layer covering the mucosal epithelial surface, & mucin molecules & increase the residence time of the dosage form at the site of the absorption.
Mucoadhesive drug delivery system is a part of controlled delivery system.
Since the early 1980,the concept of Mucoadhesion has gained considerable interest in pharmaceutical technology.
combine mucoadhesive with enzyme inhibitory & penetration enhancer properties & improve the patient complaince.
MDDS have been devloped for buccal ,nasal,rectal &vaginal routes for both systemic & local effects.
Hydrophilic high mol. wt. such as peptides that cannot be administered & poor absorption ,then MDDS is best choice.
Mucoadhesiveinner layers called mucosa inner epithelial cell lining is covered with viscoelasticfluid
Composed of water and mucin.
Thickness varies from 40 μm to 300 μm
General composition of mucus
Water…………………………………..95%
Glycoproteinsand lipids……………..0.5-5%
Mineral salts……………………………1%
Free proteins…………………………..0.5-1%
The mechanism responsible in the formation of mucoadhesive bond
Step 1 : Wetting and swelling of the polymer(contact stage)
Step 2 : Interpenetration between the polymer chains and the mucosal membrane
Step 3 : Formation of bonds between the entangled chains (both known as consolidation stage)
Electronic theory
Wetting theory
Adsorption theory
Diffusion theory
Fracture theory
Advantages over other controlled oral controlled release systems by virtue of prolongation of residence of drug in GIT.
Targeting & localization of the dosage form at a specific site
-Painless administration.
-Low enzymatic activity & avoid of first pass metabolism
If MDDS are adhere too tightlgy because it is undesirable to exert too much force to remove the formulation after use,otherwise the mucosa could be injured.
-Some patient suffers unpleasent feeling.
-Unfortunately ,the lack of standardized techniques often leads to unclear results.
-costly drug delivery system
NIOSOMES , GENERAL CHARACTERISTICS OF NIOSOME , TYPES OF NIOSOMES , OTHERS TYPES OF NIOSOMES , NIOSOMES VS LIPOSOMES , COMPONENTS OF NIOSOMES , Non-ionic surfactant , Cholesterol , Charge inducing molecule , METHOD OF PREPARATION , preparation of small unilamellar vesicles , Sonication , Micro fluidization , preparation of large unilamellar vesicles , Reverse Phase Evaporation , Ether Injection , preparation of Multilamellar vesicles , Hand shaking method , Trans membrane pH gradient drug uptake process (remote loading) , Miscellaneous method :Multiple membrane extrusion method , The “Bubble” Method , Formation of Niosomes From Proniosomes , SEPARATION OF UNENTRAPPED DRUGS , Gel Filtration , Dialysis , Centrifugation , FACTORS AFFECTING THE PHYSICOCHEMICAL PROPERTIES OF NIOSOMES , Membrane Additives , Temperature of Hydration , PROPERTIES OF DRUGS , AMOUNT AND TYPE OF SURFACTANT
Structure of Surfactants , Resistance to Osmotic Stress , Characterization of niosomes ,Therapeutic applications of Niosomes , For Controlled Release of Drugs , To Improve the Stability and Physical Properties of the Drugs , For Targeting and Retention of Drug in Blood Circulation , Proniosomes , Aspasomes , Vesicles in Water and Oil System (v/w/o) ,Bola - niosomes , Discomes , Deformable niosomes or elastic niosomes , According to the nature of lamellarity ,Small Unilamellar vesicles (SUV) 25 – 500 nm in size.,Large Unilamellar vesicles (LUV) 0.1 – 1μm in size , Multilamellar vesicles (MLV) 1-5 μm in size , According to the size:Small Niosomes (100 nm – 200 nm) , Large Niosomes (800 nm – 900 nm),Big Niosomes (2 μm – 4 μm)
Introduction
Structure
Niosomes Vs. Liposome
Advantages & Disadvantages
Properties of Niosomes
Method of Manufacturing
Evaluation of Niosomes
Applications
Marketed products
Mucoadhesive drug delivery system interact with the mucus layer covering the mucosal epithelial surface, & mucin molecules & increase the residence time of the dosage form at the site of the absorption.
Mucoadhesive drug delivery system is a part of controlled delivery system.
Since the early 1980,the concept of Mucoadhesion has gained considerable interest in pharmaceutical technology.
combine mucoadhesive with enzyme inhibitory & penetration enhancer properties & improve the patient complaince.
MDDS have been devloped for buccal ,nasal,rectal &vaginal routes for both systemic & local effects.
Hydrophilic high mol. wt. such as peptides that cannot be administered & poor absorption ,then MDDS is best choice.
Mucoadhesiveinner layers called mucosa inner epithelial cell lining is covered with viscoelasticfluid
Composed of water and mucin.
Thickness varies from 40 μm to 300 μm
General composition of mucus
Water…………………………………..95%
Glycoproteinsand lipids……………..0.5-5%
Mineral salts……………………………1%
Free proteins…………………………..0.5-1%
The mechanism responsible in the formation of mucoadhesive bond
Step 1 : Wetting and swelling of the polymer(contact stage)
Step 2 : Interpenetration between the polymer chains and the mucosal membrane
Step 3 : Formation of bonds between the entangled chains (both known as consolidation stage)
Electronic theory
Wetting theory
Adsorption theory
Diffusion theory
Fracture theory
Advantages over other controlled oral controlled release systems by virtue of prolongation of residence of drug in GIT.
Targeting & localization of the dosage form at a specific site
-Painless administration.
-Low enzymatic activity & avoid of first pass metabolism
If MDDS are adhere too tightlgy because it is undesirable to exert too much force to remove the formulation after use,otherwise the mucosa could be injured.
-Some patient suffers unpleasent feeling.
-Unfortunately ,the lack of standardized techniques often leads to unclear results.
-costly drug delivery system
‘Targeted drug delivery system is a special form of drug delivery system where the medicament is selectively targeted or delivered only to its site of action or absorption and not to the non-target organs or tissues or cells.’
Application Of Polymer In Controlled Release FormulationAnindya Jana
Polymers are becoming increasingly important in the field of drug delivery. The pharmaceutical applications of polymers range from their use as binders in tablets to viscosity and flow controlling agents in liquids, suspensions and emulsions. Polymers can be used as film coatings to disguise the unpleasant taste of a drug, to enhance drug stability and to modify drug release characteristics.
As a consequence, increasing attention has been focused on methods of giving drugs continually for a prolonged time periods and in a controlled fashion.
This technology now spans many fields and includes pharmaceutical, food and agricultural applications, pesticides, cosmetics, and household products.
‘Targeted drug delivery system is a special form of drug delivery system where the medicament is selectively targeted or delivered only to its site of action or absorption and not to the non-target organs or tissues or cells.’
Application Of Polymer In Controlled Release FormulationAnindya Jana
Polymers are becoming increasingly important in the field of drug delivery. The pharmaceutical applications of polymers range from their use as binders in tablets to viscosity and flow controlling agents in liquids, suspensions and emulsions. Polymers can be used as film coatings to disguise the unpleasant taste of a drug, to enhance drug stability and to modify drug release characteristics.
As a consequence, increasing attention has been focused on methods of giving drugs continually for a prolonged time periods and in a controlled fashion.
This technology now spans many fields and includes pharmaceutical, food and agricultural applications, pesticides, cosmetics, and household products.
Niosomes is under the Novel drug delivery system. In which the drug are enclosed in the bilayer vesicle which is made up of the phospholipid. Niosomes are the similar to the liposomes both are made up of the bilayer of phospholipid. But in niosomes several advantages of over the liposomes.
Niosomes, Aquasomes, Phytosomes,Electrosomes Molecular pharmaceutics (MPH 201T) PRESENTATION BY- NARAYAN R KOTE M PHARM [PHARMACEUTICS] ROLL NO. 8 GUIDANCE BY :- Dr . TIWARI S. S
CONTENTS
NIOSOMES
AQUASOMES
PHYTOSOMES
ELECTROSOMES
NIOSOMES
Niosomes are a novel drug delivery system, in which the medication is encapsulated in a vesicle. The vesicle is composed of a bilayer of non-ionic surface active agents and hence the name niosomes.
The niosomes are very small, and microscopic in size.
Their size lies in the nanometric scale. Although structurally similar to liposomes, they offer several advantages over them.
Niosomes have recently been shown to greatly increase transdermal drug delivery and also can be used in targeted drug delivery, and thus increased study in these structures can provide new methods for drug delivery.
STRUCTURE OF NIOSOMES
Structurally, niosomes are similar to liposomes, in that they are also made up of a bilayer.
However, the bilayer in the case of niosomes is made up of non-ionic surface active agents rather than phospholipids as seen in the case of liposomes.
Most surface active agents when immersed in water yield micellar structures however some surfactants can yield bilayer vesicles which are niosomes.
STRUCTURE OF NIOSOMES
Structurally, niosomes are similar to liposomes, in that they are also made up of a bilayer.
However, the bilayer in the case of niosomes is made up of non-ionic surface active agents rather than phospholipids as seen in the case of liposomes.
Most surface active agents when immersed in water yield micellar structures however some surfactants can yield bilayer vesicles which are niosomes.
APPLICATION OF NIOSOMES
Drug Targetting
One of the most useful aspects of niosomes is their ability to target drugs.
Niosomes can be used to target drugs to the reticuloendothelial system.It can be achieved by coating with polymer e.g. PEG.
In Diagnosis
Niosomes have also been used as carriers for iobitridol, a diagnostic agent used for X-ray imaging.
Anti-neoplastic Treatment
Most antineoplastic drugs cause severe side effects.
Niosomes can alter the metabolism; prolong circulation and half life of the drug, thus decreasing the side effects of the drugs.
Niosomes, is decreased rate of proliferation of tumor and higher plasma levels accompanied by slower elimination.Leishmaniasis :-
Leishmaniasis is a disease in which a parasite of the genus Leishmania invades the cells of the liver and spleen.
Use of niosomes in tests conducted showed that it was possible to administer higher levels of the drug without the triggering of the side effects, and thus allowed greater efficacy in treatment.
Delivery of Peptide Drugs:-
Oral peptide drug delivery has long been faced with a challenge of bypassing the enzymes which would breakdown the peptide.
Use of niosomes to successfully protect the peptides from gastrointestinal peptide breakdown is being investigated.
In an in-vitro study conducted by ODDS.
A PHARMACEUTICAL NANOSUSPENSION IS DEFINED AS: “Very finely dispers solid drug particles in an aqueous vehicale for either oral and topical use or parenteral and pulmonary administration.
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Operation “Blue Star” is the only event in the history of Independent India where the state went into war with its own people. Even after about 40 years it is not clear if it was culmination of states anger over people of the region, a political game of power or start of dictatorial chapter in the democratic setup.
The people of Punjab felt alienated from main stream due to denial of their just demands during a long democratic struggle since independence. As it happen all over the word, it led to militant struggle with great loss of lives of military, police and civilian personnel. Killing of Indira Gandhi and massacre of innocent Sikhs in Delhi and other India cities was also associated with this movement.
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
The Roman Empire A Historical Colossus.pdfkaushalkr1407
The Roman Empire, a vast and enduring power, stands as one of history's most remarkable civilizations, leaving an indelible imprint on the world. It emerged from the Roman Republic, transitioning into an imperial powerhouse under the leadership of Augustus Caesar in 27 BCE. This transformation marked the beginning of an era defined by unprecedented territorial expansion, architectural marvels, and profound cultural influence.
The empire's roots lie in the city of Rome, founded, according to legend, by Romulus in 753 BCE. Over centuries, Rome evolved from a small settlement to a formidable republic, characterized by a complex political system with elected officials and checks on power. However, internal strife, class conflicts, and military ambitions paved the way for the end of the Republic. Julius Caesar’s dictatorship and subsequent assassination in 44 BCE created a power vacuum, leading to a civil war. Octavian, later Augustus, emerged victorious, heralding the Roman Empire’s birth.
Under Augustus, the empire experienced the Pax Romana, a 200-year period of relative peace and stability. Augustus reformed the military, established efficient administrative systems, and initiated grand construction projects. The empire's borders expanded, encompassing territories from Britain to Egypt and from Spain to the Euphrates. Roman legions, renowned for their discipline and engineering prowess, secured and maintained these vast territories, building roads, fortifications, and cities that facilitated control and integration.
The Roman Empire’s society was hierarchical, with a rigid class system. At the top were the patricians, wealthy elites who held significant political power. Below them were the plebeians, free citizens with limited political influence, and the vast numbers of slaves who formed the backbone of the economy. The family unit was central, governed by the paterfamilias, the male head who held absolute authority.
Culturally, the Romans were eclectic, absorbing and adapting elements from the civilizations they encountered, particularly the Greeks. Roman art, literature, and philosophy reflected this synthesis, creating a rich cultural tapestry. Latin, the Roman language, became the lingua franca of the Western world, influencing numerous modern languages.
Roman architecture and engineering achievements were monumental. They perfected the arch, vault, and dome, constructing enduring structures like the Colosseum, Pantheon, and aqueducts. These engineering marvels not only showcased Roman ingenuity but also served practical purposes, from public entertainment to water supply.
3. NOVEL DRUG DELIVERY SYSTEM (NDDS)
Refers to approaches, formulations, technologies, and
systems for transporting a pharmaceutical compound in the
body as needed to safely achieve its desired therapeutic
effect
May involve scientific site-targeting within the body, or
facilitating systemic pharmacokinetics
Technologies modify drug release
profile, absorption, distribution and elimination for the
benefit of
Improving product efficacy and safety
Patient convenience and compliance
INTRODUCTION
4. EXAMPLES OF NDDS
• Niosomes
• Liposomes
• Nanoparticles
• Resealed erythrocytes
• Microspheres
• Monoclonal antibodies
• Micro emulsions
• Antibody-loaded drug
delivery
• Magnetic microcapsules
• Implantable pumps
Figure 1: various drug delivery systems (Aitha S, 2013)
5. Novel drug delivery system, in
which the medication is
encapsulated in a vesicle which is
composed of a bilayer of non-ionic
surface active agents (Nasir A, 2012)
Are very small, and microscopic in
size.
Although structurally similar to
liposomes, they offer several
advantages over them.
NIOSOMES
Figure 2: Niosomes Vesicles (Aitha S, 2013)
6. The vesicles forming
amphiphile is a non-ionic
surfactant stabilized by
addition of cholesterol and
small amount of anionic
surfactant such as dicetyl
phosphate
NIOSOMES
Figure 3: Vesicle of niosome (Aitha S, 2013)
7. Figure 4: Structure of Niosomes
STRUCTURE
OF NIOSOMES
similar to liposomes, in that they are also
made up of a bilayer.
However, the bilayer in the case of
Niosomes is made up of non-ionic
surface active agents rather than
phospholipids.
Made of a surfactant bilayer with its
hydrophilic ends exposed on the outside
and inside of the vesicle, while the
hydrophobic chains face each other
within the bilayer.
(Patel S.M, 2012)
(Makeshwar K.B, 2013)
8. Entrap solutes in a manner analogous to liposomes.
Osmotically active and stable.
Accommodate the drug molecules with a wide range of
solubility.
Exhibits flexibility in their structural characteristics
(composition, fluidity and size)
Performance of the drug molecules is increased.
Better availability to the particular site by protecting the
drug from biological environment.
Surfactants used in preparation are
biodegradable, biocompatible and non-immunogenic
SALIENT FEATURES OF
NIOSOMES (Makeshwar K.B, 2013)
9. Improve the therapeutic performance of the drug molecules by
Delayed clearance from the circulation
Protecting the drug from biological environment
Restricting effects to target cells
Niosomal dispersion in an aqueous phase can be emulsified in a
nonaqueous phase to
Regulate the delivery rate of drug
Administer normal vesicle in external non-aqueous phase.
Handling and storage of surfactants requires no special conditions.
Bioavailability of poorly absorbed drugs is increased.
Targeted to the site of action by oral, parenteral as well as topical
routes.
ADVANTAGES OF NIOSOMES
DELIVERY SYSTEM(Makeshwar K.B, 2013)
10. According to the nature of lamellarity
1. Multilamellar vesicles (MLV) 1-5 μm in size.
2. Large Unilamellar vesicles (LUV) 0.1 – 1μm in size
3. Small Unilamellar vesicles (SUV) 25 – 500 nm in size.
According to the size
1. Small Niosomes (100 nm – 200 nm)
2. Large Niosomes (800 nm – 900 nm)
3. Big Niosomes (2 μm – 4 μm)
TYPES OF NIOSOMES
11. Film Method
Ether Injection Method
Sonication
Reverse Phase Evaporation
Heating Method
Microfluidization
Multiple Membrane Extrusion Method
Transmembrane pH gradient (inside acidic) Drug
Uptake Process (remote Loading)
The “Bubble” Method
Formation of Niosomes from Proniosomes
METHODS OF PREPARATION
(Madhav N.V.S, 2011)
12. •Mixture of
Surfactant and
Cholesterol
Dissolved in an
organic solvent
in a round-
bottomed flask.
(e.g. diethyl
ether, chlorofor
m, etc.)
•organic solvent is
removed by low
pressure/vacuum at
room temperature
example
using a
rotary
evaporator.
• The resultant
dry surfactant
film is hydrated
by agitation at
50–60°C
Multilamellar
vesicles
(MLV) are
formed
FILM METHOD
• Also known as hand shaking method
14. A solution of the surfactant is
made by dissolving it in diethyl
ether.
This solution is then introduced using an
injection (14 gauge needle) into warm water
or aqueous media containing the drug
maintained at 60 C.
Vaporization of the ether
leads to the formation of
single layered vesicles.
• The particle size of the Niosomes formed depend on the
conditions used, and can range anywhere between 50-1000
μm. (Madhav N.V.S, 2011)
ETHER INJECTION METHOD
Figure 6: Steps of Ether injection method (Madhav N.V.S, 2011)
15. The mixture is
probe sonicated
at 60 C for 3
minutes using a
sonicator with a
titanium probe to
yield Niosomes.
Added to the
surfactant/
cholesterol
mixture in a
10 ml glass
vial
Aliquot
of drug
solution
in buffer
SONICATION
Figure 7: Sonication method (Madhav N.V.S, 2011)
16. Creation of a solution
of cholesterol and
surfactant (1:1 ratio)
in a mixture of ether
and chloroform
An aqueous phase
containing the drug
to be loaded is
added to this
Resulting two
phases are
sonicated at 4-
5 C
A clear gel is
formed which is
further sonicated
after the addition
of phosphate
buffered saline
(PBS)
Temperature is
raised to 40 C and
pressure is reduced
to remove the
organic phase
Viscous Niosome
suspension is formed
which can be diluted
with PBS and heated
on a water bath at
60 C for 10 minutes
to yield Niosomes
REVERSE PHASE EVAPORATION
(Madhav N.V.S, 2011)
17. Non-toxic, Scalable and one-step method.
HEATING METHOD
Mixtures of non-ionic
surfactant, cholesterol
and/or charge inducing
molecules are added to an
aqueous medium e.g.
buffer, distilled H2O, etc
• In the presence of a
Polyol such as glycerol.
The mixture is
heated while
stirring at low
shear forces
• Until vesicles are
formed
(Madhav N.V.S, 2011)
18. Recent technique used to prepare Unilamellar vesicles of
defined size distribution.
based on submerged jet principle
MICROFLUIDIZATION
Two fluidized
streams interact at
ultra high
velocities, in
precisely defined
micro channels
within the interaction
chamber
The impingement of thin
liquid sheet along a
common front is arranged
such that the energy
supplied to the system
remains within the area of
Niosomes formation
The result is a greater
uniformity, smaller
size and better
reproducibility of
Niosome are formed
(Madhav N.V.S, 2011)
20. Good method for controlling Niosomes size.
MULTIPLE MEMBRANE EXTRUSION
METHOD
Mixture of surfactant, cholesterol and
dicetyl phosphate in chloroform is made
into thin film by evaporation
The film is hydrated with aqueous drug
solution
Resultant suspension is extruded through
polycarbonate membranes which are
placed in series for upto 8 passages
Figure 9: Multiple membrane
extrusion method (Madhav N.V.S, 2011)
21. Solution of surfactant
and cholesterol is made
in chloroform
Solvent is then evaporated
under reduced pressure to get
a thin film on the wall of the
round bottom flask, similar to
the hand shaking method
This film is then
hydrated using citric acid
solution by vortex
mixing
Resulting Multilamellar
vesicles are then treated
to three freeze thaw
cycles and sonicated
To the Niosomal
suspension, aqueous
solution containing
10mg/ml of drug is
added and vortexed
pH of the sample is
then raised to 7.0-7.2
using 1M disodium
phosphate
Mixture is heated at
60 C for 10 minutes to
give Niosomes
TRANSMEMBRANE pH GRADIENT DRUG
UPTAKE PROCESS (Madhav N.V.S, 2011)
22. A recently developed technique which allows the preparation of
Niosomes without the use of organic solvents.
BUBBLE METHOD
The bubbling unit consists of a round bottom flask with three
necks, and this is positioned in a water bath to control the
temperature.
Water-cooled reflux and thermometer is positioned in the
first and second neck, while the third neck is used to supply
nitrogen.
Cholesterol and surfactant are dispersed together in a buffer
(pH 7.4) at 70 C.
This dispersion is mixed for a period of 15 seconds with
high shear homogenizer and immediately afterwards, it is
bubbled at 70 C using the nitrogen gas to yield Niosomes.
(Madhav N.V.S, 2011)
23. FORMATION OF NIOSOMES FROM
PRONIOSOMES (Makeshwar K.B, 2013)
Water soluble
carrier such as
sorbitol is
coated with
surfactant.
The result of the
coating process is a
dry formulation in
which each water-
soluble particle is
covered with a thin
film of dry
surfactant.
This preparation
is termed
“Proniosomes”.
The Niosomes
are recognized by
the addition of
aqueous phase at
T > Tm and brief
agitation.
T=Temperature.
Tm = mean phase transition temperature
25. 1) Dialysis:
The aqueous niosomal dispersion is dialyzed in a dialysis tubing
against phosphate buffer or normal saline or glucose solution.
2) Gel Filtration:
The unentrapped drug is removed by gel filtration of niosomal
dispersion through a Sephadex-G -50 column and elution with
phosphate buffered saline or normal saline.
3) Centrifugation:
The niosomal suspension is centrifuged and the supernatant is
separated. The pellet is washed and then resuspended to obtain a
niosomal suspension free from unentrapped drug.
POST-PREPARATION PROCESSES
(Makeshwar K.B, 2013)
26. a) Size, Shape and Morphology
b) Entrapment efficiency
c) Vesicle diameter
d) In vitro release
e) Vesicle charge
f) Bilayer rigidity and Homogeneity
g) Osmotic Shrinkage
h) Physical stability of vesicles at different temperature
i) Turbidity Measurement
CHARACTERIZATION OF NIOSOMES
(Singh C.H et al, 2011)
27. Structure of surfactant based vesicles has been visualized
and established using freeze fracture microscopy
Photon correlation spectroscopy used to determine mean
diameter of the vesicles.
Electron microscopy used for morphological studies of
vesicles
Laser beam is generally used to determine size
distribution, mean surface diameter and mass distribution of
Niosomes.
SIZE, SHAPE AND MORPHOLOGY
(Singh C.H et al, 2011)
28. After preparing Niosomal dispersion, unentrapped drug is
separated by
Dialysis
Centrifugation
Gel filtration
Drug remained entrapped in Niosomes is determined by
complete vesicle disruption using 50% n-propanol or
0.1% Triton X-100 and analysing the resultant solution by
appropriate assay method for the drug. (Bragagnia M, 2012)
ENTRAPMENT EFFICIENCY
29. To determine drug loading and encapsulation
efficiency, the niosomal aqueous suspension was
ultracentrifuged, supernatant was removed and sediment
was washed twice with distilled water in order to
remove the adsorbed drug.
The Niosomal recovery was calculated as:
NIOSOMAL DRUG LOADING
(Makeshwar K.B, 2013)
30. Niosomes diameter can be determined using
Light microscopy
Photon correlation microscopy
Freeze fracture electron microscopy.
Freeze thawing
VESICLE DIAMETER
(Shirsand S.B et al, 2012)
Figure 10: Microphotograph of Niosomes (Shrisand S.B et al, 2012)
31. At various time intervals, the buffer is analysed for the drug content by an appropriate
assay method.
The bag containing the vesicles is placed in 200 ml of buffer solution in a 250 ml beaker
with constant shaking at 25°C or 37°C.
The vesicle suspension is pipetted into a bag made up of the tubing and sealed.
A dialysis sac is washed and soaked in distilled water.
A method of in-vitro release rate study includes the use of dialysis tubing.
IN VITRO RELEASE(Makeshwar K.B, 2013)
33. The biodistribution and biodegradation of Niosomes are
influenced by rigidity of the bilayer.
Homogeneity can occur both within Niosomes structures
themselves and between Niosomes in dispersion and
could be identified via. NMR, Differential Scanning
Calorimetry (DSC) and Fourier transform-infra red
spectroscopy (FT-IR) techniques.
Membrane rigidity can be measured by means of
mobility of fluorescence probe as a function of
temperature. (Patel S.M, 2012)
BILAYER RIGIDITY AND HOMOGENEITY
34. Osmotic shrinkage of vesicles can be determined by
monitoring reductions in vesicle diameter, initiated by
addition of hypertonic salt solution to suspension of
Niosomes.
Niosomes prepared from pure surfactant are osmotically
more sensitive in contrast to vesicles containing cholesterol.
OSMOTIC SHRINKAGE
(Singh C.H et al, 2011)
35. Aggregation or fusion of vesicles as a function of
temperature was determined as the changes in vesicle
diameter by laser light scattering method.
The vesicles were stored in glass vials at room
temperature or kept in refrigerator (4oC) for 3 months.
The changes in morphology of Multilamellar vesicles
(MLVs) and also the constituent separation were assessed
by an optical microscope.
The retention of entrapped drug were measured 72 hours
after preparation and after 1, 2 or 3 months in same
formulations
PHYSICAL STABILITY OF VESICLES
AT DIFFERENT TEMPERATURE
(Singh C.H et al, 2011)
36. Niosomes were diluted with bidistilled water to give a total
lipid concentration of 0.312 mM
After rapid mixing by sonication for 5 min
Turbidity was measured as the absorbance with an
ultraviolet-visible diode array spectrophotometer.
TURBIDITY MEASUREMENT
(Singh C.H et al, 2011)
37. Niosomes as Drug Carriers
Diagnostic imaging with Niosomes
Drug Targeting
Delivery to the brain
Anti cancer drugs
Anti infectives
Targeting of bioactive agents
To Reticulo-endothelial system (RES)
To organs other than RES
NIOSOME DELIVERY APPLICATIONS
(Malhotra M, 1994)
38. Ophthalmic drug delivery
Delivery of peptide drugs
Immunological application of Niosomes
Transdermal delivery of drugs by Niosomes
Delivery system for the vasoactive intestinal peptide
(VIP)
Niosomes as carriers for Hemoglobin
Niosomal vaccines
NIOSOME DELIVERY APPLICATIONS
Nasir A. et al, (2012)
40. Unfortunately, there is not enough research conducted to
investigate toxicity of Niosomes.
It was determined that the ester type surfactants are less
toxic than ether type surfactants.
In general, the physical form of Niosomes did not
influence their toxicity as evident in a study comparing
the formulations prepared in the form of liquid crystals
and gels.
Nasal applications of these formulations caused toxicity in
the case of liquid crystal type Niosomes.
TOXICITY OF NIOSOMES
Vyas S.P, 2011
41. 1. Aitha, S. (2013). slideshare. Retrieved 2014, from http://www.slideshare.net/swethaaitha/liposomes-
and-niosomes-15259272
2. Bragagnia M, Natascia M. (2012). Development and Characterization of Niosomal Formulations of
Doxorubicin Aimed at Brain Targeting. Journal of Pharmaceutical science, 184-196.
3. Madhav N.V.S, Saini A. (2011). Niosomes: A Novel Drug Delivery System. International Journal of
Research in Pharmacy and Chemistry, 1(3), 498-511.
4. Makeshwar K.B, Wasankar S. (2013). Niosome: a Novel Drug Delivery System. Asian Journal of
Pharmapress, 3(1), 16-20.
5. Malhotra M, Jain N. (1994). Niosomes as drug carriers (Vol. 31). Newdelhi: Indian Drugs.
6. Nasir A, Harikumar S.L, Kaur A. (2012). Niosomes: An Excellent Tool for Drug Delivery.
International Journal of Research in Pharmacy and Chemistry, 2(2), 479-487.
7. Patel S.M, Rathod D.R. (2012). Niosome as an Effective Drug Delivery: A Review. International
Journal for Pharmaceutical Research Scholars, 46-53.
8. Shirsand S.B, Para M.S, Kanani K.M, Keerthy D, Kumar N.D. (2012). Formulation and evaluation
of Ketoconazole niosomal gel drug delivery system. Int J Pharma investig, 201-207.
9. Singh C.H, Jain C.P, Bairwa N.K. (2011). Formulation, characterization, stability and invitro
evaluation of nimesulide niosomes. Pharmacophore, 2, 168-185.
10. Vyas SP, Khar. R. (2011). Targeted and Controlled Drug Delivery Novel carrier systems. New delhi:
CBS Publisher and Distributors.
REFERENCE